Orbit Discovery and Endevica Bio Enter Multi-Target Collaboration | |
Compass Therapeutics to Present Phase 2 Data of CTX-009 with Paclitaxel at ASCO GI Cancers Symposium | |
Wall Street Journal: Ovation Gathers Funding to Extend Research Network | |
Adimab Provides 2022 Update on Clinical Pipeline | |
Adimab Provides Year-End Update on 2022 Partnership Activities | |
Compass Therapeutics Announces First Patient Dosed in Phase 2 Study of CTX-009 | |
